{
  "id": "7c939680-d51b-453f-bc5a-fd08afd08b2f",
  "patient_id": "bc8a3bb5-01b7-4bbd-a79a-43f812620f3a",
  "encounter_id": "5f9f4650-7af0-451a-813d-6693489bdc44",
  "analysis_type": "Genetic Testing Recommendation",
  "input_text": "Patient: Steven Ortega, DOB: 2006-02-16, Gender: Male\n\nChief Complaint: headache\n\nS: Patient Describes no history of illness\n\nO: No physical exam documented.\n\nA: No assessment documented.\n\nP: No plan documented.\n\n--- IMAGING & SCANS ---\n- ECG (3/25/2025): ECG Scan for Patient\n\n--- IMAGING & SCANS ANALYSIS ---\n\n[Scan 1: ECG (2025-03-25T09:09:28.833517)]\nFile: norm.png\nDescription: ECG Scan for Patient\nAnalysis: Okay, let's analyze this ECG tracing. Here\u2019s a detailed breakdown of what I see, incorporating observations and potential considerations:\n\n**Overall Impression:**\n\nThis ECG appears to represent a sinus rhythm, but with some notable features that warrant careful attention. The rhythm is relatively regular, but there are several abnormalities present that suggest a potential underlying cardiac issue.\n\n**Detailed Analysis (Lead by Lead):**\n\n* **Rate:** The heart rate appears to be approximately 75-80 beats per minute. This is within the normal range (60-100 bpm).\n* **Rhythm:** The rhythm is generally regular, though there are some slight irregularities that require further evaluation.\n* **P Waves:**  The P waves are present and generally upright in leads I, aVL, V1, V2, V5, and V6.  However, they appear somewhat peaked and may be slightly bizarre in morphology, particularly in V1. This can be a sign of underlying issues.\n* **PR Interval:** The PR intervals are variable. Some appear slightly prolonged, particularly in leads V1 and V6. A prolonged PR interval can suggest a first-degree AV block.\n* **QRS Complexes:** This is where the most significant abnormalities are observed.\n    * **Morphology:** The QRS complexes are wide (greater than 0.12 seconds) in most leads, particularly V1, V2, V5, and V6. This is a key finding.\n    * **Q Waves:**  There are subtle Q waves present in some leads, notably V5 and V6. The Q waves are small and not clearly defined, but their presence should be noted.\n    * **R Wave Progression:** The R wave progression appears somewhat uneven across the leads, which is consistent with the wide QRS complexes.\n* **ST Segment:** The ST segments are generally isoelectric (flat) in most leads. However, there are some subtle elevations in the ST segments in V5 and V6, particularly during the T wave.\n* **T Waves:** The T waves are predominantly negative in most leads, but they exhibit inversion in V1 and V2.  The T wave morphology is generally rounded.\n* **QT Interval:** The QT interval is difficult to precisely measure on this tracing due to the wide QRS complexes. However, it appears to be prolonged.  A prolonged QT interval increases the risk of ventricular arrhythmias.\n* **Axis:** The overall\n\n\n--- MEDICAL ENTITY ANALYSIS ---\n\nHISTORY: DOB, 2006-02-16, history of illness\nDETAILED_DESCRIPTION: Male, by Lead, ,, V, first, degree, T wave\nSIGN_SYMPTOM: headache, sinus rhythm, abnormalities, irregularities, P, P waves, peaked, Q waves, elevations, inversion\nDIAGNOSTIC_PROCEDURE: physical exam, assessment, plan, ECG, rhythm, Rate, heart rate, Rhythm, Waves, PR Interval, PR intervals, PR interval, QRS Complexes, ology, QRS complexes, Q Waves, R Wave Progression, R wave progression, S, ST Segment, ST segments, T Waves, T waves, T wave morphology, QT Interval, QT interval\nDATE: 25, 03-25, 09:09:28\nLAB_VALUE: regular, 75-80 beats per minute, upright, bizarre, variable, prolonged, wide, greater than 0.12 seconds, small, defined, uneven, isoelectric, flat, negative, rounded\nDISEASE_DISORDER: cardiac issue, AV block, ventricular arrhythmias\nSEVERITY: slight, subtle\nBIOLOGICAL_STRUCTURE: leads I, aVL, V1, V2, V5, V6, leads V1 and, 6, V1,, V2,, leads, ST segments, V5 and V6",
  "recommendation": "Unknown",
  "reasoning": "The ECG shows several abnormalities suggestive of a potential underlying cardiac issue.  Specifically, the wide QRS complexes (greater than 0.12 seconds), subtle Q waves in leads V5 and V6, uneven R wave progression, and potentially prolonged QT interval raise concerns about conditions like Long QT Syndrome (LQTS) or Brugada Syndrome.  The literature indicates that LQTS can present with variable PR intervals and T-wave abnormalities, while Brugada syndrome is characterized by ST segment elevation in leads V1-V3.  The patient's age (19 years old) falls within the typical age range for the onset of symptoms in these conditions. While the patient's chief complaint is a headache, the ECG findings significantly outweigh this seemingly benign symptom.  The absence of a detailed physical exam and medical history limits the ability to definitively diagnose a specific condition, but the ECG abnormalities strongly suggest the need for further investigation. Genetic testing would help identify potential underlying genetic causes of these cardiac abnormalities, allowing for appropriate management and risk stratification.  An exercise ECG could also be helpful to further investigate potential arrhythmias.",
  "confidence": "70%",
  "model_used": "Gemini-Pro",
  "retrieved_docs": [
    {
      "id": "rws_txt_7",
      "contents": "stablishing a specifc genetic cause of long QT syndrome (LQ \u2022 Can aid in discussions of prognosis (which are beyond the scope of this GeneReview) and genetic counseling; \u2022 Usually involves a medical history, physical examination, family history, and genomic/genetic testing. \n\nClinical history. Clinical history in individuals with syncope or a cardiac arrest can reveal specifc triggers for the cardiac event that can be gene specifc. On rare occasions LQTS is accompanied by gene-spe cifc extracardiac features. \nPhysical examination. Te great majority of individuals with LQTS do not have associated physical features. On rare occasions, LQTS is accompanied by gene-specifc extracardiac features. Individuals with EKG characteristics suggestive of a specifc LQTS-associated syndrome (e.g., EKG with T-U patterns characteristic of Andersen-Tawil syndrome) can be assessed for physical features of that syndrome. \nFamily history. A three-generation family history should be taken, with attention to relatives with manifestations of LQTS \u2013 including syncope, aborted cardiac arrest, or sudden death in a child or (young) adult \u2013 and documentation of relevant fndings through direct examination or review of medical records, including results of molecular genetic testing and EKG recordings. Specifc focus should also be on triggers of events in relatives, as well as epilepsy (LQTS-associated syncopes may have been attributed to epilepsy). In such instances, review of medical records should include EEG recordings, accompanied by an EKG, which can show QTc prolongation in afected family members. \nEKG evaluation. Te corrected QT (QTc) values on resting EKG and ST-T wave morphology can suggest a specifc genetic cause of LQTS (see Table 2). Additional tests can be helpful to unmask QTc prolongation in individuals with borderline QTc values on resting EKG [Priori et al 2013]: \n\u2022 Exercise EKG, which commonly shows failure of the QTc to shorten normally and even prolongation of the QTc interval [Jervell & Lange-Nielsen 1957, Vincent et al 1991, Swan et al 1998, Horner et al 2011, Sy et al 2011].",
      "token_count": 484,
      "sentence_count": 17
    },
    {
      "id": "barth_txt_9",
      "contents": " Spencer et al [2006] observed that with standard cardiac medications for dilated cardiomyopathy more than 16/30 afected males had normal ejection fraction and lef ventricular diastolic volume. However, some responded to therapy initially but deteriorated afer a period of stability, requiring cardiac transplantation [Adwani et al 1997, Mangat et al 2007]. \nArrhythmia. Te risk for arrhythmia (including supraventricular and ventricular tachycardia) and sudden death is increased. While arrhythmia has been most ofen reported in adolescents and young adults, it can occur in children of all ages. EKG abnormalities can include repolarization abnormalities and prolonged QTc intervals. \nAll 20 afected males with EKGs in the French cohort had a normal sinus rhythm. Repolarization abnormalities (including ST fattening and T-wave inversion) were seen in 17. Five had QTc values within the normal range (QTc ${<}420\\;\\mathrm{ms}_{}$ ), and fve had QTc greater than $460\\:\\mathrm{ms}$ . Te median QTc was $440\\:\\mathrm{ms}$ (range: $360{-}530~\\mathrm{ms})$ ). In the study by Kang et al [2016], nine of 21 afected individuals had prolonged QTc of greater than $460~\\mathrm{ms}$ and three had borderline QTc prolongation between 450 and $460~\\mathrm{ms}$ . \nIn fve instances of ventricular arrhythmia leading to cardiac arrest or placement of an internal defbrillato r [Spencer et al 2005]: \n\u2022 All fve individuals had normal QTc intervals;   \n\u2022 All fve had a history of recurrent vasovagal symptoms including postural dizziness, nausea, and pallor suggestive of autonomic instability;   \n\u2022 Four had only mild LV dilatation and low normal to mildly depressed LV function; only one had poor but stable LV function prior to cardiac arrest;   \n\u2022 Tree showed inducible ventricular arrhythmias on electrophysiologic testing;   \n",
      "token_count": 479,
      "sentence_count": 15
    },
    {
      "id": "cvt_txt_3",
      "contents": "\u2022 History of exercise- or emotion-related palpitations and dizziness in some individuals   \n\u2022 Sudden unexpected cardiac death triggered by acute emotional stress or exercise   \n\u2022 Family history of juvenile sudden cardiac death triggered by exercise or acute emotion   \n\u2022 Exercise-induced bidirectional or polymorphic ventricular arrhythmias \u26ac EKG during a graded exercise (exercise stress test) \\* allows ventricular arrhythmias to be reproducibly elicited in the majority of afected individuals. Typically, the onset of ventricular arrhythmias is 90-120 beats per minute. \u26ac With increase in workload, the complexity of arrhythmias progressively increases from isolated premature beats to bigeminy and runs of non-sustained ventricular tachycardia (VT). If the afecte d individual continues exercising, the duration of the runs of VT progressively increases and VT may become sustained. \u26ac An alternating $180^{\\circ}$ -QRS axis on a beat-to-beat basis, so-called bidirectional VT, is ofen the distinguishing presentation of CPVT arrhythmias [Priori et al 2021]. \u26ac Notably, some individuals with CPVT may also present with irregular polymorphic VT without a \"stable\" QRS vector alternans [Swan et al 1999, Priori et al 2002]. \u26ac Exercise-induced supraventricular arrhythmias (supraventricular tachycardia and atrial fbrillatio n) are common [Leenhardt et al 1995, Fisher et al 1999]. \n\u2022 Ventricular fbrillation occurring in the setting of acute stress \\* Note: Te resting EKG of individuals with CPVT is usually normal. Some authors have reported a lower-thannormal resting heart rate [Postma et al 2005] and others have observed a high incidence of prominent U waves, particularly in the precordial leads [Leenhardt et al 1995, Aizawa et al 2006]. Overall, these features are inconsistent and not sufciently specifc to allow diagnosis. Terefore, in many instances the origin of the syncope may be erroneously attributed to a neurologic disorder. Te exercise stress test is the single most important diagnostic test.",
      "token_count": 485,
      "sentence_count": 15
    },
    {
      "id": "brugada_txt_7",
      "contents": " Electrical storms (also known as arrhythmic storms) \u2013 multiple episodes of ventricular \narrhythmias that occur over a short period of time \u2013 are malignant but rare phenomena in Brugada syndrome.   \nIncessant ventricular tachycardia (VT) is defned as hemodynamically stable VT continuing for hours. \nBrugada syndrome can occur in conjunction with conduction disease. Te presence of frst-degree AV block, intraventricular conduction delay, right bundle branch block, and sick sinus syndrome in Brugada syndrome is not unusual [Smits et al 2005]. \nClinical presentations of Brugada syndrome may also include sudden infant death syndrome (SIDS; death of a child during the frst year of life without an identifable cause) [Priori et al 2000, Antzelevitch 2001, Skinner et al 2005, Van Norstrand et al 2007] and sudden unexpected nocturnal death syndrome (SUNDS) [Vatta et al 2002], a syndrome seen in Southeast Asia in which young people die from cardiac arrest with no identifable cause.  Te same pathogenic variant in SCN5A was identifed in individuals with Brugada syndrome and SUNDS, thus supporting the hypothesis that they are the same disease [Hong et al 2004a]. \nPrecipitating factors for the Brugada EKG pattern and the syndrome of sudden cardiac death include fever, cocaine use, electrolyte disturbances, and use of class I antiarrhythmic medications and a number of other noncardiac medications [Francis & Antzelevitch 2005]. Most importantly, in some (usually young) persons, the presence of the induced EKG pattern has been associated with sudden cardiac death. Te pathophysiologic mechanisms behind this association remain largely unknown. \nPredicting risk of malignant arrhythmias. Several parameters have been investigated to improve stratifcatio n of the risk of developing malignant arrhythmias (see Figure 3). \n\u2022 Inducibility during electrophysiologic study (EPS) is the only parameter currently used for clinical decision making. During such a study the heart is electrically stimulated using intracardiac catheters.",
      "token_count": 464,
      "sentence_count": 14
    },
    {
      "id": "brugada_txt_29",
      "contents": "Ikeda T, Takami M, Sugi K, Mizusawa Y, Sakurada H, Yoshino H. Noninvasive risk stratifcation of subjects with a Brugada-type electrocardiogram and no history of cardiac arrest. Ann Noninvasive Electrocardiol. 2005;10:396\u2013403. PubMed PMID: 16255748.   \nImaki R, Niwano S, Fukaya H, Sasaki S, Yuge M, Hirasawa S, Sato D, Sasaki T, Moriguchi M, Izumi T. Predictive impact of the inducibility of ventricular fbrillation in patients with Brugada-type ECG. Int Heart J. 2006;47:229\u201336. PubMed PMID: 16607050.   \nIto H, Yano K, Chen R, He Q, Curb JD. Te prevalence and prognosis of a Brugada-type electrocardiogram in a population of middle-aged Japanese-American men with follow-up of three decades. Am J Med Sci. 2006;331:25\u20139. PubMed PMID: 16415660.   \nKapplinger JD, Tester DJ, Alders M, Benito B, Berthet M, Brugada J, Brugada P, Fressart V, Guerchicof A, Harris-Kerr C, Kamakura S, Kyndt F, Koopmann TT, Miyamoto Y, Pfeifer R, Pollevick GD, Probst V, Zumhagen S, Vatta M, Towbin JA, Shimizu W, Schulze-Bahr E, Antzelevitch C, Salisbury BA, Guicheney P, Wilde AA, Brugada R, Schott JJ, Ackerman MJ. An international compendium of mutations in the SCN5Aencoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing. Heart Rhythm. 2010;7:33\u201346. PubMed PMID: 20129283.   \nKaraca M, Dinckal MH. Monomorphic and propafenone-induced polymorphic ventricular tachycardia in Brugada syndrome: a case report. Acta Cardiol. 2006;61:481\u20134.",
      "token_count": 485,
      "sentence_count": 24
    },
    {
      "id": "brugada_txt_32",
      "contents": " Manifestation of Brugada syndrome afer pacemaker implantation in a patient with sick sinus syndrome. J Cardiovasc Electrophysiol. 2004;15:1328\u201330. PubMed PMID: 15574187.   \nNamiki T, Ogura T, Kuwabara Y, et al. Five-year mortality and clinical characteristics of adult subjects with right bundle branch block and ST elevation. Circulation. 1995;93:334.   \nNunn L, Bhar-Amato J, Lambiase P. Brugada syndrome: controversies in risk stratifcation and management. Indian Pacing Electrophysiol J. 2010;10:400\u20139. PubMed PMID: 20930958.   \nOe H, Takagi M, Tanaka A, Namba M, Nishibori Y, Nishida Y, Kawarabayashi T, Yoshiyama M, Nishimoto M, Tanaka K, Yoshikawa J. Prevalence and clinical course of the juveniles with Brugada-type ECG in Japanese population. Pacing Clin Electrophysiol. 2005;28:549\u201354. PubMed PMID: 15955188.   \nOhno S, Zankov DP, Ding WG, Itoh H, Makiyama T, Doi T, Shizuta S, Hattori T, Miyamoto A, Naiki N, Hancox JC, Matsuura H, Horie M. KCNE5 (KCNE1L) variants are novel modulators of Brugada syndrome and idiopathic ventricular fbrillation. Circ Arrhythm Electrophysiol. 2011;4:352\u201361. PubMed PMID: 21493962.   \nOlson TM, Alekseev AE, Moreau C, Liu XK, Zingman LV, Miki T, Seino S, Asirvatham SJ, Jahangir A, Terzic A. KATP channel mutation confers risk for vein of Marshall adrenergic atrial fbrillation. Nat Clin Pract Cardiovasc Med. 2007;4:110\u20136. PubMed PMID: 17245405.   \n",
      "token_count": 458,
      "sentence_count": 28
    },
    {
      "id": "thompson_thompson_genetics_8th_edition_medicoscompanion_com_txt_767",
      "contents": "LQT syndrome is caused by repolarization defects in cardiac cells. Repolarization is a controlled process that requires a balance between inward currents of sodium and calcium and outward currents of potassium. Imbalances cause the action potential of cells to increase or decrease in duration, causing elongation or shortening, respectively, of the QT interval on electrocardiography. Most cases of LQT syndrome are caused by loss-of-function mutations in genes that encode subunits or regulatory proteins for potassium channels (genes whose names begin with KCN). These mutations decrease the outward, repolarization current, thereby prolonging the action potential of the cell and lowering the threshold for another depolarization. In other LQT syndrome patients, gain-of-function mutations in a sodium channel gene, SCN5A, lead to an increased influx of sodium, resulting in similar shifting of action potential and repolarization effects. \nPhenotype and Natural History \nThe LQT syndromes are characterized by elongated QT interval and T-wave abnormalities on electrocardiography (Fig. C-28), including tachyarrhythmia and torsades de pointes, a ventricular tachycardia characterized by a change in amplitude and twisting of the QRS complex. Torsades de pointes is associated with a prolonged QT interval and typically stops spontaneously but may persist and worsen to ventricular fibrillation. \n\nIn the most common LQT syndrome, Romano-Ward, syncope due to cardiac arrhythmia is the most frequent symptom; if undiagnosed or left untreated, it recurs and can be fatal in $10\\%$ to $\\bar{1}5\\%$ of cases. However, between $30\\%$ and $50\\%$ of individuals with the syndrome never show syncopal symptoms. Cardiac episodes are most frequent from the preteen years through the 20s, with the risk decreasing over time. Episodes may occur at any age when triggered by QTprolonging medications (see list at http://www.qtdrugs.org). Nonpharmacological triggers for cardiac events in the Romano-Ward syndrome differ on the basis of the gene responsible. LQT1 triggers are typically adrenergic stimuli, including exercise and sudden emotion.",
      "token_count": 492,
      "sentence_count": 16
    },
    {
      "id": "timothy_txt_8",
      "contents": " Lower-than-normal heart rate is frequently observed prenatally or at birth in individuals with markedly increased QT prolongation that causes intermittent 2:1 AV block (see following). In other individuals, sinus bradycardia has been reported in the absence of AV block.   \n\u2022 Other electrocardiographic manifestations that are common in individuals with gain-of-function CACNA1C pathogenic variants may include: \u26ac AV block. Te 2:1 AV block is likely caused by the extremely prolonged ventricular repolarization and refractory periods and not by AV node malfunction. \u26ac Macroscopic T-wave alternans. Positive and negative T waves on a beat-to-beat basis   \n\u2022 Tachyarrhythmia / sudden death. Associated with the prolonged QTc interval, ventricular tachyarrhythmias (including ventricular tachycardia and ventricular fbrillation) are reported. Arrhythmias are more ofen polymorphic ventricular tachycardia and torsade de pointes that may degenerate and leading to cardiac arrest. Syncope may occur due to self-limiting ventricular tachycardia.   \n\u2022 Cardiovascular malformations are reported to include patent ductus arteriosus, patent foramen ovale, ventricular septal defect, tetralogy of Fallot, or hypertrophic cardiomyopathy. \nLoss-of-function pathogenic variants \n\u2022 Short QT syndrome is associated with a short QT interval with or without Brugada syndrome EKG pattern due to a reduction of the duration of cardiac action potential. Te evidence of QTc ${<}350\\;\\mathrm{ms}$ is a hallmark of increased sudden death risk [Mazzanti et al 2017]. No specifc trigger for arrhythmic events has been identifed. Autism can be present in association with short QT interval [Endres et al 2020]. \u2022 Brugada syndrome manifests clinically with the typical EKG pattern of ST elevation in V1 and V2 leads. Arrhythmic events and sudden death typically occur at rest or during sleep. \nExtracardiac Manifestations \n",
      "token_count": 461,
      "sentence_count": 19
    },
    {
      "id": "acpp_txt_2",
      "contents": "\u2022 Periodic paralysis Symptomatic cardiac arrhythmias or electrocardiographic evidence of enlarged U-waves, ventricular ectopy, or a prolonged QTc or QUc interval Characteristic facies, dental anomalies, small hands and feet, AND at least two of the following: \u26ac Low-set ears \u26ac Widely spaced eyes \u26ac Small mandible \u26ac Fifh-digit clinodactyly \u26ac Syndactyly of toes 2 and 3 \nB. One of the above three criteria AND at least one other family member who meets two of the three criteria [Statland et al 2018] \nSupportive Findings \nIndividuals with either episodic weakness or cardiac symptoms require careful evaluation by a neurologist and/or cardiologist as well as measurement of serum potassium concentration (baseline and during attacks of faccid paralysis), a 12-lead EKG, a 24-hour Holter monitor, and possibly the long exercise protocol. \n\u2022 Serum potassium concentration during episodes of weakness may be elevated, normal, or, most commonly, reduced $^{(<3.5\\;\\mathrm{mmol}/\\mathrm{U})}$ [Sansone & Tawil 2007, Statland et al 2018]. \n\u2022 Routine nerve conduction electrophysiology is normal between episodes. A more sensitive electrophysiologic study, the long exercise protocol, may reveal an immediate post-exercise increment followed by an abnormal decrement in the compound motor action potential amplitude $(\\sqrt{\\frac{}{}40\\%})$ [Katz et al 1999] or area $(>\\!50\\%)$ 20-40 minutes post exercise [Kuntzer et al 2000, Fournier et al 2004]. In a study of 11 individuals with ATS, $82\\%$ met long-exercise amplitude decrement criteria for abnormal testing [Tan et al 2011]. \u2022 Electrocardiogram may reveal characteristic abnormalities including prominent U waves, prolonged Q-U intervals, premature ventricular contractions, polymorphic ventricular tachycardia, and bidirectional ventricular tachycardia [Zhang et al 2005, Delannoy et al 2013, Koppikar et al 2015, Statland et al 2018].",
      "token_count": 479,
      "sentence_count": 11
    },
    {
      "id": "friedreich_txt_9",
      "contents": " A longitudinal study identifed two groups; a \"low risk\" group (approximately $80\\%$ ) with normal ejection fraction that declined slowly and remained in the normal range and a \"high risk\" group (approximately $20\\%$ ) in whom ejection fraction declined into the abnormal range and was associated with high mortality [Pousset et al 2015]. Tose in the \"high risk\" group had longer GAA expansions on the shorter allele. Te degree of neurologic impairment did not predict whether an afected individual would have stable or rapid progression of cardiomyopathy. \nElectrocardiography (EKG) is abnormal in the vast majority, with T wave inversion, lef axis deviation, and repolarization abnormalities being most commonly seen [Dutka et al 1999]. \nSymptoms related to cardiomyopathy usually occur in the later stages of the disease [Dutka et al 1999] but in rare instances may precede ataxia [Alika\u015fifoglu et al 1999, Leonard & Forsyth 2001]. Quercia et al [2010] established the diagnosis of FRDA in a young child evaluated for sudden death. Subjective symptoms of exertional dyspnea $(40\\%)$ , palpitations $(11\\%)$ , and anginal pain may be present in moderately advanced disease. Arrhythmias (especially atrial fbrillation) and congestive heart failure frequently occur in the later stages of the disease and are the most common cause of mortality [Tsou et al 2011]. Coronary artery disease may occur and should be considered if there is angina and/or sudden deterioration in cardiac function [Giugliano & Sethi 2007]. \nUrinary issues. Bladder symptoms including urinary frequency and urgency were reported by $41\\%$ of individuals in one study [Delatycki et al 1999a]. A study of 158 individuals with FRDA revealed lower urinary tract symptoms in $82\\%$ with impact on quality of life in $22\\%$ of those [Musegante et al 2013]. Of 28 who underwent urodynamic studies, all had normal serum creatinine and four had upper urinary tract dilatation. \nSleep-disordered breathing.",
      "token_count": 479,
      "sentence_count": 14
    },
    {
      "id": "propionic-a_txt_10",
      "contents": "Te age of PA diagnosis, frequency of metabolic decompensation, and residual enzymatic activity do not correlate with presence/absence of cardiomyopathy in individuals with PA [Romano et al 2010].   \n\u2022 Rarely, cardiomyopathy can occur as an apparently isolated clinical phenomenon in previously healthy individuals without documented episodes of metabolic decompensation or neurocognitive defcits [Lee et al 2009, Laemmle et al 2014].   \n\u2022 Cardiomyopathy can progress to cardiac failure and may be associated with sudden death [Dionisi-Vici et al 2006]. \nCardiac rhythm abnormalities. A prolonged QT interval is ofen detected in individuals with PA [K\u00f6lker et al 2015b]. Tis can be associated with syncope, arrhythmia, and cardiac arrest [Baumgartner et al 2007, Jameson & Walter 2008, Pena & Burton 2012]. \nGastrointestinal manifestations \n\u2022 Pancreatitis (reported in $3\\%{-}18\\%$ of individuals) may be recurrent and may present with anorexia, recurrent nausea, and abdominal pain [Dionisi-Vici et al 2006, Gr\u00fcnert et al 2012, Pena & Burton 2012]. In some individuals recurrent pancreatitis can lead to insulin-dependent diabetes.   \n\u2022 Poor feeding and lack of appetite are common, afecting up to $76\\%$ of afected individuals [Touati et al 2006].   \n\u2022 Emesis and diarrhea are commonly reported in individuals with PA, becoming a recurrent problem in approximately $6\\%$ [K\u00f6lker et al 2015b].   \n\u2022 Liver issues include hepatomegaly, hypoalbuminemia, and abnormal liver function tests (ALT, AST, GGT, INR, and bilirubin) [Karimzadeh et al 2014, K\u00f6lker et al 2015b]. Te etiology of hepatic dysfunction has not been determined with certainty but may include the inherent metabolic derangement as well as cardiac dysfunction in individuals with cardiomyopathy. \nRenal abnormalities have been infrequently documented and are likely underreported.",
      "token_count": 459,
      "sentence_count": 14
    },
    {
      "id": "cadasil_txt_7",
      "contents": " Acute encephalopathy has been described in some individuals, with confusion, headache, pyrexia, seizures, and coma, sometimes leading to death [Adib-Samii et al 2010, Ragno et al 2013, Tan & Markus 2016]. Migraine with aura (especially confusional aura) is associated with increased risk of acute encephalopathy, suggesting that they may share pathophysiologic mechanisms [Tan & Markus 2016]. \nEpilepsy. Epilepsy occurs in $10\\%$ of individuals with CADASIL and presents in middle age, usually secondary to stroke [Haan et al 2007]. In a pooled analysis of previous published cases, three of 105 individuals with CADASIL had a seizure as the initial presenting symptom [Desmond et al 1999]. \nPregnancy. It has been suggested that the risk for migraine with aura is increased during pregnancy, but especially during puerperium (the period between childbirth and the return of the uterus to its normal size) [Roine et al 2005]. Another study found no association between pregnancy and risk for neurologic events or problems during pregnancy [Donnini et al 2017]. See Pregnancy Management. \nOther fndings \n\u2022 Cardiac. Controversy exists as to whether CADASIL is associated with cardiac involvement. In a study from Te Netherlands, nearly $25\\%$ of individuals with CADASIL had a history of acute myocardial infarction (MI) and/or current pathologic Q-waves on electrocardiogram (EKG) [Lesnik Oberstein et al 2003]. Tis percentage was signifcantly higher than in controls without a heterozygous NOTCH3 pathogenic variant. However, another study of 23 individuals with CADASIL found no signs of previous MI on EKG [Cumurciuc et al 2006b]. Two studies have suggested an increased risk for arrhythmias, based on increased QT variability on EKG recording [Rufa et al 2007, Piccirillo et al 2008].   \n\u2022 Nerve. Nerve biopsies may demonstrate signs of axonal damage, demyelination, and ultrastructural changes of the endoneurial blood vessels [Schr\u00f6der et al 2005, Sicurelli et al 2005, Lackovic et al 2012].",
      "token_count": 485,
      "sentence_count": 14
    },
    {
      "id": "hyper-pp_txt_2",
      "contents": "\u2022 History of at least two attacks of faccid limb weakness (which may also include weakness of the muscles of the eyes, throat, breathing muscles, and trunk)   \n\u2022 Onset or worsening of an attack as a result of oral potassium intake   \n\u2022 Disease manifestations before age 20 years   \n\u2022 Absence of cardiac arrhythmia between attacks   \n\u2022 Normal psychomotor development \nFamily history \n\u2022 Typically, at least one afected frst-degree relative \u2022 Note: Absence of a family history suggestive of hyperPP does not preclude the diagnosis. \nElectromyogram (EMG) \n\u2022 During the attack, EMG demonstrates a reduced number of motor units or may be silent (no insertional or voluntary activity).   \n\u2022 In the intervals between attacks, EMG may reveal myotonic activity (bursts of muscle fber action potentials with amplitude and frequency modulation, fring rate generally between 20 and $150\\,\\mathrm{Hz}$ ), even though myotonic stifness may not be clinically present.   \n\u2022 In some individuals, especially in those with permanent weakness, a myopathic pattern may be visible.   \n\u2022 Note: Approximately $50\\%$ of afected individuals have no detectable electric myotonia. \nSuggestive laboratory fndings during attacks \n\u2022 Hyperkalemia (serum potassium concentration $>5\\;\\mathrm{mmol/L}$ ) or an increase of serum potassium concentration of at least $1.5\\;\\mathrm{mmol/L}$ .   \n\u2022 Note: Serum potassium concentration seldom reaches cardiotoxic levels, but changes in the EKG (increased amplitude of T waves) may occur.   \n\u2022 Elevated serum creatine kinase (CK) concentration (sometimes 5-10x the normal range) \nSuggestive laboratory fndings between attacks \n\u2022 Normal serum potassium concentration and muscle strength between attacks Note: At the end of an attack of weakness, elimination of potassium via the kidney and reuptake of potassium by the muscle can cause transient hypokalemia that may lead to the misdiagnosis of hypokalemic periodic paralysis. \u2022 Elevated serum CK concentration with normal serum sodium concentration \nEstablishing the Diagnosis \n",
      "token_count": 448,
      "sentence_count": 21
    },
    {
      "id": "brugada_txt_1",
      "contents": "Brugada syndrome is characterized by cardiac conduction abnormalities (ST segment abnormalities in leads $\\mathrm{V}_{1}$ - $\\mathrm{V}_{3}$ on EKG and a high risk for ventricular arrhythmias) that can result in sudden death. Brugada syndrome presents primarily during adulthood, although age at diagnosis may range from infancy to late adulthood.  Te mean age of sudden death is approximately 40 years. Clinical presentations may also include sudden infant death syndrome (SIDS; death of a child during the frst year of life without an identifable cause) and sudden unexpected nocturnal death syndrome (SUNDS), a typical presentation in individuals from Southeast Asia. Other conduction defects can include frst-degree AV block, intraventricular conduction delay, right bundle branch block, and sick sinus syndrome. \nDiagnosis/testing \nTe diagnosis of Brugada syndrome is established clinically in an individual with characteristic EKG fndin gs and suggestive clinical history and/or family history. A molecular diagnosis can be established in an individual with characteristic features and identifcation of a heterozygous pathogenic variant in SCN5A or one of the additional 42 genes associated with Brugada syndrome. \nManagement \nTreatment of manifestations: Implantable cardioverter defbrillator (ICD) in individuals with a history of syncope or cardiac arrest; isoproterenol for electrical storms. During surgery and in the postsurgical recovery period persons with Brugada syndrome should be monitored by EKG. \nPrevention of primary manifestations: Quinidine ( $1{\\mathrm{-}}2\\ {\\mathrm{g}}$ daily). Treatment of asymptomatic individuals is controversial. \nSurveillance: EKG monitoring every one to two years for at-risk individuals with a family history of Brugada syndrome or who have a known pathogenic variant that can lead to Brugada syndrome. \n",
      "token_count": 414,
      "sentence_count": 13
    },
    {
      "id": "26431_txt_22",
      "contents": " For the connective tissue disorders identifed in task 1, identify the types of treatments available and describe to the degree possible: \na. The clinical practice guidelines for receiving the treatments;   \nb. The settings in which the treatments are provided;   \nc. What receipt of the treatments indicates about the clinical or medical severity of the medical condition;   \nd. The likelihood of improvement when receiving the treatments and the period over which the improvement would be expected; and   \ne. Any limitations on the availability of the treatments (other than due to fnancial circumstances or the patient\u2019s preferences), such as whether treatments are considered experimental, remain in the trial phase, or are limited to certain geographic areas. \n\n4. For the connective tissue disorders identifed in task 1, provide a summary of selected treatments currently being studied in clinical trials. \n5. For the connective tissue disorders identifed in task 1, identify to the degree possible the functional limitations associated with each disorder, including physical functioning limitations, mental functioning limitations, limitations resulting from common treatments, and variations in functioning (e.g., during fare-ups vs. remission), and how such limitations would present in a typical medical record. \n6. For the connective tissue disorders identifed in task 1, identify nonexertional physical limitations (e.g., balancing or using the upper extremities for fne or gross movements) and mental limitations (e.g., cognitive or behavioral) that are equivalent in severity to the standard represented in the listings (i.e., that would prevent any gainful activity) but are not captured by currently existing listings and are not currently refected in SSA\u2019s disability grid rules. \nrt will include consensus conclusions but not recommenda \nIn the report, when terms such as \u201cseverity\u201d or \u201csevere\u201d are used, the committee shall identify to the degree possible whether the term is being used with SSA\u2019s work-related program defnition (i.e., an impairment of such severity as to be the basis of a fnding of an inability to engage in any substantial gainful activity) or as it is used in the clinical or medical care settings, and, if necessary, will specify the pertinent differences between the two defnitions. \nThe committee shall not describe issues with respect to access to treatments due to fnancial circumstances, including insurance limitations.",
      "token_count": 492,
      "sentence_count": 18
    },
    {
      "id": "del2q37_2_txt_10",
      "contents": "\u2022 Complete physical and dysmorphology examination   \n\u2022 Determination of head circumference, height, weight, and other anthropometric measurements   \n\u2022 Specialty evaluation of obesity or failure to thrive   \n\u2022 Multidisciplinary developmental and neurologic evaluation to assess motor and cognitive skills as well as autism, autism spectrum behaviors, and other behavioral issues   \n\u2022 Echocardiogram to evaluate for congenital cardiac anomaly   \n\u2022 Renal ultrasound examination to evaluate for possible Wilms tumor, renal malformation, or other renal problems Ophthalmology evaluation for strabismus and/or refractive errors   \n\u2022 Audiologic assessment for possible hearing loss   \n\u2022 Brain imaging studies (MRI, CT scan) in individuals with abnormal neurologic fndings   \n\u2022 EEG for evaluation of seizures and treatment monitoring   \n\u2022 X-ray to evaluate for the presence of scoliosis and skeletal anomalies examination. While the clinical implications of osteopenia have not been studied in the 2q37 microdeletion syndrome, clinicians should be aware that this is a common fnding. X-rays should be performed at diagnosis and should be repeated as warranted by clinical examination. Te youngest individual with osteopenia in the authors' series is age three years.   \n\u2022 Consultation with a clinical geneticist and/or genetic counselor \nTreatment of Manifestations \nDepending on the age and presenting concerns of the individual with the 2q37 microdeletion syndrome, care from specialists in the following areas is ofen necessary: clinical genetics, speech pathology, occupational and physical therapy, child development, neurology, cardiology, gastroenterology, nutrition/feeding in cases of failure to thrive, ophthalmology, and audiology. \nMedical care may be coordinated by a clinical geneticist or other health care professional skilled at managing patients with complex needs. \nInfants beneft from enrollment in an early-intervention program. Most school-age children beneft from an individualized educational program (IEP) with input from a multispecialty group of physical, occupational, and speech therapists with pediatric assessment. \nPrevention of Secondary Complications \nAt this time, it is not known why many individuals with the 2q37 microdeletion syndrome are obese. To the extent that it is feasible, the authors recommend an active lifestyle and good dietary habits to help avoid development of obesity. \nSurveillance \n",
      "token_count": 475,
      "sentence_count": 23
    },
    {
      "id": "thompson_thompson_genetics_8th_edition_medicoscompanion_com_txt_541",
      "contents": "Established standards of medical care require that providers of genetic services obtain a history that includes family and ethnic information, inquire as to possible consanguinity, advise patients of the genetic risks to them and other family members, offer genetic testing or prenatal diagnosis when indicated, and outline the various treatment or management options for reducing the risk for disease. Although genetic counseling case management must be individualized for each patient\u2019s needs and situation, a generic approach can be summarized (Table 16-2). In general, patients are not told what decisions to make with regard to the various testing and management options but are instead provided with information and support in coming to a decision that seems most appropriate for the patients, the consultands, and their families. This approach to counseling, referred to as nondirective counseling, has its origins in the setting of prenatal counseling, where the guiding principle is respect for an individual couple\u2019s autonomy, that is, their right to make reproductive choices free of coercion (see Chapter 19). \n\nManaging the Risk for Recurrence in Families \nMany families seek genetic counseling to ascertain the risk for heritable disease in their children and to learn what options are available to reduce the risk for recurrence of the particular genetic disorder in question. Genetic laboratory tests for carrier testing (karyotyping, biochemical analysis, or genome analysis) are frequently used to determine the actual risk to couples with a family history of a genetic disorder. Genetic counseling is recommended both before and after such testing, to assist consultands in making an informed decision to undergo testing, as well as to understand and to use the information gained through testing. \nWhen family history or laboratory testing indicate an increased risk for a hereditary condition in a future pregnancy, prenatal diagnosis, described in Chapter 17, is one approach that can often be offered to families. Prenatal diagnosis is, however, by no means a universal solution to the risk for genetic problems in offspring. There are disorders for which prenatal diagnosis is not available and, for many parents, pregnancy termination is not an acceptable option, even if prenatal diagnosis is available. Preimplantation diagnosis by blastocyst or blastomere biopsy (see Chapter 17) avoids the problems of pregnancy termination but requires in vitro fertilization. \nOther measures besides prenatal diagnosis are available for the management of recurrence and include the following: \n",
      "token_count": 494,
      "sentence_count": 13
    },
    {
      "id": "A_Guide_To_Marfan_Syndrome_and_Related_Disorders_txt_14",
      "contents": " More information about these disorders is provided in section V of this book. \nNo specific diagnosis \nThis is when a person has Marfan features but does not meet the diagnostic criteria for any known disorder. Many people with \nMarfan features (whether they have a diagnosis or not) need medical treatment and follow-up care. Make sure to talk with your doctor about the care that is right for you. \nMany people with Marfan features (whether they have a diagnosis or not) need medical treatment and follow-up care. Talk with your doctor about the care that is right for you. \n1.ROUTINE TREATMENT \nThere is no cure for Marfan syndrome. However, a range of treatment options can minimize and sometimes prevent complications. Appropriate specialists will develop individualized treatment programs and the approach a doctor uses depends on which systems are affected. \nEvery person needs a physician who can be turned to for \u201croutine\u201d illnesses and questions. Most physicians who provide these services know about Marfan syndrome only superficially, and may not feel comfortable taking care of the specialized problems that people with Marfan syndrome might develop. In addition to a personal physician (usually an internist, pediatrician or general practitioner), it is important to have one doctor who understands all aspects of Marfan syndrome\u2014someone who can evaluate all of the systems that might be affected, coordinate referral to specialists when needed, and counsel about prognosis, treatment and inheritance. \nThis doctor may be a medical geneticist, most of whom tend to be located at medical centers affiliated with medical schools, as are many of the specialists who have the most experience with Marfan syndrome. For most people, an annual or semi-annual visit to such a center will provide the necessary medical follow-up for Marfan syndrome. \nFollowing are some of the important treatment considerations by body system. \nAbout half of all people with Marfan syndrome develop scoliosis, although only about one third of those need treatment. \nA. Bones & Joints (Skeletal System) \ni. Scoliosis \nScoliosis is a spinal curvature in which the vertebrae twist, usually into an S-shape or spiral shape. It is caused by the abnormally loose ligaments of the spine and the rapid growth of the child with Marfan syndrome. Scoliosis can affect any part of the spine, and it may be mild or severe.",
      "token_count": 468,
      "sentence_count": 23
    },
    {
      "id": "sca37_txt_8",
      "contents": "Evaluations Following Initial Diagnosis \nTo establish the extent of disease and needs in an individual diagnosed with spinocerebellar ataxia type 37 (SCA37), the evaluations summarized in this section (if not performed as part of the evaluation that led to the diagnosis) are recommended: \nPhysical examination \n\u2022 Neurologic assessment   \n\u2022 Assessment of the full range of symptoms associated with a progressive cerebellar syndrome. Among a range of clinical scoring systems that have been described [Saute et al 2012], the Scale for the Assessment and Rating of Ataxia (SARA) [Schmitz-H\u00fcbsch et al 2006] provides a reliable and consistent assessment of most of the clinical features and progression of SCA37.   \n\u2022 Electrooculographic tests may properly assess progression at the onset of disease.   \n\u2022 Specifc assessment of the cerebellar cognitive afective syndrome may be considered.   \n\u2022 Brain MRI examination   \n\u2022 Consultation with speech, physical, behavioral, and occupational therapists   \n\u2022 Consultation with a clinical geneticist and/or genetic counselor \nTreatment of Manifestations \nNo curative treatment is available for individuals with SCA37. Palliative care includes the following: \nSpeech therapy to improve communication and ameliorate dysphagia Tickness modifcation of food and fuids to prevent aspiration Physical therapy to train balance \u2022 Use of external devices (e.g., canes or walkers) when needed to avoid falls \u2022 Occupational/behavior therapy \nSurveillance \nTe following are appropriate: \n\u2022 SARA score annually. Note: SARA may not detect disease progression for the frst fve to seven years. \u2022 Electrooculographic tests may be performed every two years (cooperation is required). \u2022 Brain MRI volumetry every two years \nEvaluation of Relatives at Risk \nSee Genetic Counseling for issues related to testing of at-risk relatives for genetic counseling purposes. \nTherapies Under Investigation \nSearch ClinicalTrials.gov in the US and EU Clinical Trials Register in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: Tere may not be clinical trials for this disorder. \nGenetic Counseling \nGenetic counseling is the process of providing individuals and families with information on the nature, mode(s) of inheritance, and implications of genetic disorders to help them make informed medical and personal decisions.",
      "token_count": 462,
      "sentence_count": 30
    },
    {
      "id": "saul-wilson_txt_8",
      "contents": "BCVA $=$ best-corrected Snellen visual acuity; $\\mathrm{BMD}=$ bone mineral density; $\\mathrm{ERG=}$ electroretinography; FTT $=$ failure to thrive; $\\mathrm{HC}=$ head circumference; $H\\Gamma=$ height; $\\mathrm{OCT=}$ optical coherence tomography; $\\mathrm{OT}=$ occupational therapy; $\\mathrm{PT}=$ physical therapy; ${\\mathrm{SNHL}}=$ sensorineural hearing loss; $\\mathrm{SWS}=:$ Saul-Wilson syndrome; ${\\mathrm{WT}}=$ weight   \n1. See Hereditary Hearing Loss and Deafness Overview for details about audiologic evaluations. \nTreatment of Manifestations \nable 4. Treatment of Manifestations in Individuals with Saul-Wilson Syn \nDevelopmental Delay Management Issues \nTe following information represents typical management recommendations for individuals with developmental delay in the United States; standard recommendations may vary from country to country. \nAges 0-3 years. Referral to an early intervention program is recommended for access to occupational, physical, speech, and feeding therapy. In the US, early intervention is a federally funded program available in all states that provides in-home services to target individual therapy needs. \nAges 3-5 years. In the US, developmental preschool through the local public school district is recommended. Before placement, an evaluation is made to determine needed services and therapies and an individualized education plan (IEP) is developed for those who qualify based on established motor, language, social, or cognitive delay. Te early intervention program typically assists with this transition. Developmental preschool is center based. \nAll ages. Consultation with a developmental pediatrician is recommended to ensure the involvement of appropriate community, state, and educational agencies (US) and to support parents in maximizing quality of life. Some issues to consider: \nIEP services: \n\u26ac An IEP provides specially designed instruction and related services to children who qualify. \u26ac IEP services will be reviewed annually to determine whether any changes are needed. \u26ac Special education law requires that children participating in an IEP be in the least restrictive environment feasible at school and included in general education as much as possible, when and where appropriate.",
      "token_count": 481,
      "sentence_count": 20
    },
    {
      "id": "christianson_txt_9",
      "contents": "\u2022 Establishment of baseline neurologic functioning with: \u26ac Assessment of adaptive functioning (e.g., Vineland, Bayley Scales of Infant Development) \u26ac Occupational therapy and physical therapy assessment regarding fne motor and gross motor functioning \u26ac Speech/language/communication assessment \u26ac Assessment of behavioral issues, as needed, using such evaluation tools as Autism Diagnostic Observation Schedule (ADOS) and Autism Diagnostic Interview-Revised (ADI-R)] \u26ac Neurologic examination \u26ac EEG \u26ac Brain MRI (based on the clinician's judgment) to determine if any structural brain abnormalities are present, especially cerebellar / brain stem atrophy   \n\u2022 Evaluation of swallowing function, feeding, and nutrition as needed   \n\u2022 Ophthalmologic assessment, including evaluation for eye movement abnormalities and visual acuity, when warranted   \n\u2022 Consultation with a clinical geneticist and/or genetic counselor \nTreatment of Manifestations \nDevelopmental Delay / Intellectual Disability Management Issues \nTe following information represents typical management recommendations for individuals with developmental delay / intellectual disability in the United States; standard recommendations may vary from country to country. \nAges 0-3 years. Referral to an early intervention program is recommended for access to occupational, physical, speech, and feeding therapy. In the US, early intervention is a federally funded program available in all states. \nAges 3-5 years. In the US, developmental preschool through the local public school district is recommended. Before placement, an evaluation is made to determine needed services and therapies, and an individualized education plan (IEP) is developed. \nAges 5-21 years \n\u2022 In the United States, an IEP based on the individual's level of function should be developed by the local public school district. Afected children are permitted to remain in the public school district until age 21. Discussion regarding transition plans and medical arrangements should begin at age 12 years. Developmental pediatricians can provide assistance with transition to adulthood. \nAll ages. Consultation with a developmental pediatrician is recommended to ensure the involvement of appropriate community, state, and educational agencies and to support parents in maximizing quality of life. \nConsideration of private supportive therapies based on the afected individual's needs is recommended. Spe cifc recommendations regarding type of therapy can be made by a developmental pediatrician. \nIn the US: \n\u2022 Developmental Disabilities Administration (DDA) enrollment is recommended.",
      "token_count": 473,
      "sentence_count": 23
    },
    {
      "id": "kmt2b-dystonia_txt_11",
      "contents": "Early initiation of physiotherapy and a tailored exercise program is essential to maintain function and prevent secondary orthopedic complications such as joint contractures, hip dislocation, and/or kyphoscoliosis. \nAdaptive aids (e.g., ankle-foot orthoses, walkers) should be supplied to support and maintain ambulation. \nSpeech and language therapy is crucial to assist in feeding skills and communication. Some afected individuals may need communication devices. \nNutrition specialists / dieticians are of utmost importance to assess calorie needs and reduce the risk of malnutrition. \nVideofuoroscopy can be used to evaluate the risk of aspiration and assess the need for alternative means of feeding. \nFor individuals with respiratory compromise from chest deformities related to scoliosis, prophylactic antibiotics during the winter months, regular physiotherapy, and infuenza immunizations should be considered because of the increased risk of pulmonary infections. \nDevelopmental Delay / Intellectual Disability Management Issues \nTe following information represents typical management recommendations for individuals with developmental delay / intellectual disability in the United States; standard recommendations may vary from country to country. \nAges 0-3 years. Referral to an early intervention program is recommended for access to occupational, physical, speech, and feeding therapy. In the US, early intervention is a federally funded program available in all states. \nAges 3-5 years. In the US, developmental preschool through the local public school district is recommended. Before placement, an evaluation is made to determine needed services and therapies and an individualized education plan (IEP) is developed. \nAges 5-21 years \n\u2022 In the US, an IEP based on the individual's level of function should be developed by the local public school district. Afected children are permitted to remain in the public school district until age 21. \u2022 Discussion about transition plans including fnancial, vocation/employment, and medical arrangements should begin at age 12 years. Developmental pediatricians can provide assistance with transition to adulthood. \nAll ages. Consultation with a developmental pediatrician is recommended to ensure the involvement of appropriate community, state, and educational agencies and to support parents in maximizing quality of life. \nConsideration of private supportive therapies based on the afected individual's needs is recommended.",
      "token_count": 474,
      "sentence_count": 23
    },
    {
      "id": "26431_txt_43",
      "contents": " The impact on the individual in terms of functional limitations and restrictions results from the combined effects of the multiple impairments in different body systems, which may be severe collectively even if they are individually graded as \u201cless severe.\u201d This interplay among impairments and the multisystem nature of HDCTs can pose a major difficulty for the global assessment of disease severity. \nThe functional impairment in HDCTs is also linked to limitations and necessary restrictions due to vulnerability to specific environmental factors and other stressors. For many HDCTs, a patient\u2019s disease severity, manifestations, and clinical course may be adversely affected by specific environmental factors. In addition, physical and mental demands related to school or work may precipitate or exacerbate secondary impairments, \nCopyright National Academy of Sciences. All rights reserved. \nperhaps further limiting activities and restricting participation. Beyond diagnosis of a specific HDCT, informed clinicians can help their patients substantially by being attuned to the many physical and mental secondary impairments with which these patients present. Recognizing the presence of these conditions and taking action to address them, even in the absence of confirmatory genetic testing, can mitigate their effects on the functional status and quality of life of individuals with HDCTs. \nDISEASE STATE MANAGEMENT \nCentral to minimizing the impact of HDCTs on function is a coordinated multidisciplinary management strategy (Miklovic and Sieg, 2021; Mittal et al., 2021). Medical management needs to include a complete body-system review and assessment and periodic monitoring for areas of vulnerability. Functional management needs to address physical vulnerabilities and may require lifelong rehabilitation services. Psychosocial support of patients and families is also important. As noted previously, psychiatric manifestations, including anxiety and depression, are frequently seen in these conditions, as is the case in patients with other chronic conditions. Simple screening tools for depression and anxiety are available for use in the primary care setting. If these conditions are found to be present, a comprehensive mental health evaluation is important, and management may require ongoing assessment and treatment. \nHigh-quality care for individuals with HDCTs relies on effective coordination among a team of providers across a broad range of disciplines (Miklovic and Sieg, 2021; Mittal et al., 2021).",
      "token_count": 460,
      "sentence_count": 19
    },
    {
      "id": "charge_txt_15",
      "contents": " Evaluation of bony landmarks and the structure and pathways of the vestibular and facial nerves (which can be abnormal) is important in surgical planning [Vesseur et al 2016c]. See also Figure 5.   \n3. In some individuals, an aberrant course of the facial nerve may be a contraindication for cochlear implant [Vesseur et al 2016a, Vesseur et al 2016c]. \nReproduced from de Geus et al [2017] \nDevelopmental Delay / Intellectual Disability Management Issues \nTe following information represents typical management recommendations for individuals with developmental delay / intellectual disability in the United States; standard recommendations may vary from country to country. \nAges 0-3 years. Referral to an early intervention program is recommended for access to occupational, physical, speech, and feeding therapy as well as infant mental health services, special educators, and sensory impairment specialists. In the US, early intervention is a federally funded program available in all states and provides inhome services to target individual therapy needs. \nAges 3-5 years. In the US, developmental preschool through the local public school district is recommended. Before placement, an evaluation is made to determine needed services and therapies and an individualized education plan (IEP) is developed for those who qualify based on established motor, language, social or cognitive delay. Te early intervention program typically assists with this transition. Developmental preschool is center based; for children too medically unstable to attend, home-based services may be provided. \nAll ages. Consultation with a developmental pediatrician is recommended to ensure the involvement of appropriate community, state, and educational agencies and to support parents in maximizing quality of life. Some issues to consider: \n\u2022 IEP services: \n\u26ac An IEP provides specially designed instruction and related services to children who qualify. \u26ac IEP services will be reviewed annually to determine whether any changes are needed. \u26ac Special education law requires that children participating in an IEP be in the least restrictive environment feasible at school and included in general education as much as possible, when and where appropriate. \u26ac Vision and hearing consultants should be a part of the child's IEP team to support access to academic material. \u26ac PT, OT, and speech services will be provided in the IEP to the extent that the need afects the child's access to academic material.",
      "token_count": 471,
      "sentence_count": 22
    },
    {
      "id": "scan1_txt_5",
      "contents": "\u2022 Complete neurologic examination including use of the Scale for the Assessment and Rating of Ataxia (SARA) and assessment of muscle strength, refexes, and sensation   \n\u2022 Assessment by specialists in rehabilitation medicine, occupational therapy, and physical therapy regarding gross motor skills, fne motor skills, and need for adaptive equipment such as prostheses, walking aids, and/or wheelchairs   \n\u2022 Assessment by a speech-language pathologist for evidence of dysarthria and need for ongoing speechlanguage therapy   \n\u2022 Consultation with a medical geneticist, certifed genetic counselor, or certifed advanced genetic nurse to inform afected individuals and their families about the nature, mode of inheritance, and implications of SCAN1 in order to facilitate medical and personal decision making \nTo support the family of an individual diagnosed with SCAN1, review of the following options is recommended: \n\u2022 Use of community or online resources (e.g., Parent to Parent)   \n\u2022 Social work involvement for parental support   \n\u2022 Home nursing referral (if needed)   \n\u2022 Ethics consultation (clinical ethics services) to assess health care decisions in the context of the best interest of the child and the values and preferences of the family \nTreatment of Manifestations \nTere is no cure for SCAN1. \nSupportive care is provided by specialists in neurology, rehabilitation medicine, occupational therapy, physical therapy, speech-language pathology, and clinical genetics. \nPhysical therapy may be helpful in maintaining a more active lifestyle. \nSurveillance \nRoutine follow up as determined by treating specialists is recommended to monitor the response to supportive care and to assess for changes in existing manifestations and/or emergence of new manifestations. \nAgents/Circumstances to Avoid \nLikely to be extremely harmful and possibly fatal: \nExposure to genotoxic anti-cancer drugs such as camptothecins (e.g., irinotecan and topotecan) and bleomycin [Hirano et al 2007]   \n\u2022 Exposure to radiation [El-Khamisy et al 2007] \nEvaluation of Relatives at Risk \nSee Genetic Counseling for issues related to testing of at-risk relatives for genetic counseling purposes. \nTherapies Under Investigation \nSearch ClinicalTrials.gov in the US and EU Clinical Trials Register in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: Tere may not be clinical trials for this disorder. \nGenetic Counseling \n",
      "token_count": 477,
      "sentence_count": 28
    },
    {
      "id": "sotos_txt_13",
      "contents": "To establish the extent of disease and needs in an individual diagnosed with Sotos syndrome, the following evaluations (if not performed as part of the evaluation that led to the diagnosis) are recommended [TattonBrown & Rahman 2007]: \n\u2022 A thorough history to identify known features of Sotos syndrome: learning difculties, cardiac and renal anomalies, seizures, and scoliosis   \n\u2022 Physical examination including cardiac auscultation, blood pressure measurement, and back examination for scoliosis   \n\u2022 Investigations to detect abnormalities before they result in signifcant morbidity or mortality: \u26ac In children in whom the diagnosis has just been established, echocardiogram and renal ultrasound examination \u26ac In adults in whom the diagnosis has just been established, renal ultrasound examination to evaluate for kidney damage from quiescent chronic vesicoureteral refux \u26ac Referral for audiologic assessment. Conductive hearing loss may occur at an increased frequency in Sotos syndrome; thus, the threshold for referral should be low. \n\u2022 Consultation with a clinical geneticist and/or genetic counselor \nTreatment of Manifestations \nWhen clinical manifestations (e.g., cardiac anomalies, renal anomalies, scoliosis, or seizures) are identified, referral to the appropriate specialist is recommended. \nIf brain MRI has been performed and ventricular dilatation demonstrated, shunting should not usually be necessary as the \"arrested hydrocephalus\" associated with Sotos syndrome is typically not obstructive and not associated with raised intracranial pressure. If raised intracranial pressure is suspected, investigation and management in consultation with neurologists and neurosurgeons would be appropriate. \nDevelopmental Delay / Intellectual Disability Management Issues \nFor difculties with learning/behavior/speech that can be found in individuals with Sotos syndrome, the following information represents typical management recommendations for individuals with developmental delay / intellectual disability in the United States; standard recommendations may vary from country to country. \nAges 0-3 years. Referral to an early intervention program is recommended for access to occupational, physical, speech, and feeding therapy. In the US, early intervention is a federally funded program available in all states. \nAges 3-5 years. In the US, developmental preschool through the local public school district is recommended. Before placement, an evaluation is made to determine needed services and therapies and an individualized education plan (IEP) is developed. \n",
      "token_count": 493,
      "sentence_count": 19
    },
    {
      "id": "edm-ad_txt_9",
      "contents": "To establish the extent of disease and needs in an individual diagnosed with multiple epiphyseal dysplasia (MED), the evaluations summarized in this section (if not performed as part of the evaluation that led to the diagnosis) are recommended: \nElicitation of pain history   \nAssessment of joint mobility   \nRadiographs to determine the extent and severity of joint involvement   \nConsultation with a clinical geneticist and/or genetic counselor \nTreatment of Manifestations \nFor pain control, a combination of analgesics and physiotherapy including hydrotherapy is helpful to many afected individuals; however, pain can be difcult to control. Referral to a rheumatologist or pain specialist may be indicated. \nLimitation of joint destruction and the development of osteoarthritis is a goal. Consultation with an orthopedic surgeon can determine if realignment osteotomy and/or acetabular osteotomy may be helpful in slowing the progression of symptoms. \nIn some individuals, total joint arthroplasty may be required if the degenerative hip changes are causing too much pain or dysfunction. \nPsychosocial support addressing issues of short stature, chronic pain, disability, and employment is appropriate. \nSurveillance \nEvaluation by an orthopedic surgeon is recommended if the afected individual has chronic pain or limb deformities (genu varum, genu valgum). \nAgents/Circumstances to Avoid \nTe following should be avoided: \nObesity, which increases stress on joints \u2022 Exercise that causes repetitive strain on afected joints \nEvaluation of Relatives at Risk \nSee Genetic Counseling for issues related to testing of at-risk relatives for genetic counseling purposes. \nTherapies Under Investigation \nSearch ClinicalTrials.gov in the US and EU Clinical Trials Register in Europe for information on clinical studies for a wide range of diseases and conditions. Note: Tere may not be clinical trials for this disorder. \nGenetic Counseling \nGenetic counseling is the process of providing individuals and families with information on the nature, mode(s) of inheritance, and implications of genetic disorders to help them make informed medical and personal decisions.  Te following section deals with genetic risk assessment and the use of family history and genetic testing to clarify genetic status for family members; it is not meant to address all personal, cultural, or ethical issues that may arise or to substitute for consultation with a genetics professional. \u2014ED. \nMode of Inheritance \n",
      "token_count": 484,
      "sentence_count": 27
    },
    {
      "id": "mga3_txt_8",
      "contents": "To establish the extent of disease and needs in an individual diagnosed with Costef syndrome, the evaluations summarized in Table 3 (if not performed as part of the evaluation that led to the diagnosis) are recommended. \nTreatment of Manifestations \nTreatment is supportive. A multidisciplinary team including a neurologist, orthopedic surgeon, ophthalmologist, biochemical geneticist, and physical therapist is required for the care of afected individuals. \nDevelopmental Delay / Intellectual Disability Management Issues \nTe following information represents typical management recommendations for individuals with developmental delay / intellectual disability in the United States; standard recommendations may vary from country to country. \nAges 0-3 years. Referral to an early intervention program is recommended for access to occupational, physical, speech, and feeding therapy as well as infant mental health services, special educators, and sensory impairment specialists. In the US, early intervention is a federally funded program available in all states that provides inhome services to target individual therapy needs. \n\nAges 3-5 years. In the US, developmental preschool through the local public school district is recommended. Before placement, an evaluation is made to determine needed services and therapies and an individualized education plan (IEP) is developed for those who qualify based on established motor, language, social, or cognitive delay. Te early intervention program typically assists with this transition. Developmental preschool is center based; for children too medically unstable to attend, home-based services are provided. \nAll ages. Consultation with a developmental pediatrician is recommended to ensure the involvement of appropriate community, state, and educational agencies (US) and to support parents in maximizing quality of life. Some issues to consider: \nIEP services: \n\u26ac An IEP provides specially designed instruction and related services to children who qualify. \u26ac IEP services will be reviewed annually to determine whether any changes are needed. \u26ac Special education law requires that children participating in an IEP be in the least restrictive environment feasible at school and included in general education as much as possible, when and where appropriate. \u26ac Vision and hearing consultants should be a part of the child's IEP team to support access to academic material. \u26ac PT, OT, and speech services will be provided in the IEP to the extent that the need afects the child's access to academic material.",
      "token_count": 469,
      "sentence_count": 22
    },
    {
      "id": "gr_22q13_3_txt_17",
      "contents": " Genetic testing that reveals deletion of 22q13.3 is ofen the manner in which individuals erroneously diagnosed with cerebral palsy receive the correct diagnosis. \nSpastic paraplegia. Because children with Phelan-McDermid syndrome have delayed motor milestones and may walk with an unsteady, \"spastic\" gait, they may be misdiagnosed as having spastic paraplegia. However, individuals with hereditary spastic paraplegia are distinguished by progressive weakness and spasticity of the lower extremities. Individuals with complex spastic paraplegia may also display neurologic dysfunction including seizures, dementia, and amyotrophy. Spastic paraplegia encompasses a number of neurologic disorders with X-linked, autosomal recessive, or autosomal dominant inheritance. Individuals with Phelan-McDermid syndrome do not demonstrate progressive neurologic symptoms characteristic of hereditary spastic paraplegia, yet they may carry this diagnosis until genetic testing that identifes Phelan-McDermid syndrome is performed. \nManagement \nEvaluations Following Initial Diagnosis \nTo establish the extent of disease and needs in an individual diagnosed with Phelan-McDermid syndrome, the evaluations summarized in Table 4 (if not performed as part of the evaluation that led to diagnosis) are recommended. \nTreatment of Manifestations \nTreatment is symptomatic; no specifc therapy is available. Te following are appropriate interventions. \nTable 5. Treatment of Manifestations in Individuals with Phelan-McDermid Syndrome \nDevelopmental Delay\u00a0/ Intellectual Disability Management Issues \nTe following information represents typical management recommendations for individuals with developmental delay / intellectual disability in the United States; standard recommendations may vary from country to country. \nAges 0-3 years. Referral to an early intervention program is recommended for access to occupational, physical, speech, and feeding therapy. In the US, early intervention is a federally funded program available in all states. \nAges 3-5 years. In the US, developmental preschool through the local public school district is recommended. Before placement, an evaluation is made to determine needed services and therapies and an individualized education plan (IEP) is developed. \nAges 5-21 years \n\u2022 In the US, an IEP based on the individual's level of function should be developed by the local public school district.",
      "token_count": 482,
      "sentence_count": 24
    }
  ],
  "scan_analyses": [
    {
      "scan_type": "ECG",
      "scan_date": "2025-03-25T09:09:28.833517",
      "file_name": "norm.png",
      "description": "ECG Scan for Patient",
      "analysis": "Okay, let's analyze this ECG tracing. Here\u2019s a detailed breakdown of what I see, incorporating observations and potential considerations:\n\n**Overall Impression:**\n\nThis ECG appears to represent a sinus rhythm, but with some notable features that warrant careful attention. The rhythm is relatively regular, but there are several abnormalities present that suggest a potential underlying cardiac issue.\n\n**Detailed Analysis (Lead by Lead):**\n\n* **Rate:** The heart rate appears to be approximately 75-80 beats per minute. This is within the normal range (60-100 bpm).\n* **Rhythm:** The rhythm is generally regular, though there are some slight irregularities that require further evaluation.\n* **P Waves:**  The P waves are present and generally upright in leads I, aVL, V1, V2, V5, and V6.  However, they appear somewhat peaked and may be slightly bizarre in morphology, particularly in V1. This can be a sign of underlying issues.\n* **PR Interval:** The PR intervals are variable. Some appear slightly prolonged, particularly in leads V1 and V6. A prolonged PR interval can suggest a first-degree AV block.\n* **QRS Complexes:** This is where the most significant abnormalities are observed.\n    * **Morphology:** The QRS complexes are wide (greater than 0.12 seconds) in most leads, particularly V1, V2, V5, and V6. This is a key finding.\n    * **Q Waves:**  There are subtle Q waves present in some leads, notably V5 and V6. The Q waves are small and not clearly defined, but their presence should be noted.\n    * **R Wave Progression:** The R wave progression appears somewhat uneven across the leads, which is consistent with the wide QRS complexes.\n* **ST Segment:** The ST segments are generally isoelectric (flat) in most leads. However, there are some subtle elevations in the ST segments in V5 and V6, particularly during the T wave.\n* **T Waves:** The T waves are predominantly negative in most leads, but they exhibit inversion in V1 and V2.  The T wave morphology is generally rounded.\n* **QT Interval:** The QT interval is difficult to precisely measure on this tracing due to the wide QRS complexes. However, it appears to be prolonged.  A prolonged QT interval increases the risk of ventricular arrhythmias.\n* **Axis:** The overall"
    }
  ],
  "medical_entities": {
    "HISTORY": [
      "DOB",
      "2006-02-16",
      "history of illness"
    ],
    "DETAILED_DESCRIPTION": [
      "Male",
      "by Lead",
      ",",
      "V",
      "first",
      "degree",
      "T wave"
    ],
    "SIGN_SYMPTOM": [
      "headache",
      "sinus rhythm",
      "abnormalities",
      "irregularities",
      "P",
      "P waves",
      "peaked",
      "Q waves",
      "elevations",
      "inversion"
    ],
    "DIAGNOSTIC_PROCEDURE": [
      "physical exam",
      "assessment",
      "plan",
      "ECG",
      "rhythm",
      "Rate",
      "heart rate",
      "Rhythm",
      "Waves",
      "PR Interval",
      "PR intervals",
      "PR interval",
      "QRS Complexes",
      "ology",
      "QRS complexes",
      "Q Waves",
      "R Wave Progression",
      "R wave progression",
      "S",
      "ST Segment",
      "ST segments",
      "T Waves",
      "T waves",
      "T wave morphology",
      "QT Interval",
      "QT interval"
    ],
    "DATE": [
      "25",
      "03-25",
      "09:09:28"
    ],
    "LAB_VALUE": [
      "regular",
      "75-80 beats per minute",
      "upright",
      "bizarre",
      "variable",
      "prolonged",
      "wide",
      "greater than 0.12 seconds",
      "small",
      "defined",
      "uneven",
      "isoelectric",
      "flat",
      "negative",
      "rounded"
    ],
    "DISEASE_DISORDER": [
      "cardiac issue",
      "AV block",
      "ventricular arrhythmias"
    ],
    "SEVERITY": [
      "slight",
      "subtle"
    ],
    "BIOLOGICAL_STRUCTURE": [
      "leads I",
      "aVL",
      "V1",
      "V2",
      "V5",
      "V6",
      "leads V1 and",
      "6",
      "V1,",
      "V2,",
      "leads",
      "ST segments",
      "V5 and V6"
    ]
  },
  "analysis_date": "2025-03-25T13:40:01.092202",
  "created_at": "2025-03-25T13:40:01.092206"
}